Sagimet Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $509.33 million, with shareholders equity totaling $256.15 million.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, Sagimet Biosciences Inc. reported $- in revenue, generating net income of $-47.08 million.
Key financial metrics include a P/E ratio of -10.82, a price-to-book (P/B) ratio of 1.99, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker SGMT.